Terms: = Pancreatic cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
6 results:
1. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer.
Ou ZL; Luo Z; Lu YB
World J Gastroenterol; 2019 Dec; 25(46):6728-6742. PubMed ID: 31857775
[TBL] [Abstract] [Full Text] [Related]
2. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
[TBL] [Abstract] [Full Text] [Related]
3. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
[TBL] [Abstract] [Full Text] [Related]
4. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract] [Full Text] [Related]
5. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical demonstration of c-kit protooncogene product in gallbladder cancer.
Tanaka S; Tanaka H; Yamamoto T; Shuto T; Takemura S; Hai S; Sakabe K; Uenishi T; Hirohashi K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):228-34. PubMed ID: 16708300
[TBL] [Abstract] [Full Text] [Related]